(1S)-N-[[(7S)-2,5-dimethoxy-7-bicyclo[4.2.0]octa-1,3,5-trienyl]methyl]-1-phenylethanamine | 912440-91-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 茚满类
• 英文名称: (1S)-N-[[(7S)-2,5-dimethoxy-7-bicyclo[4.2.0]octa-1,3,5-trienyl]methyl]-1-phenylethanamine
• CAS: 912440-91-6
• 化学式: C₁₉H₂₃NO₂
• 分子量: 297.397
• InChiKey: QVSFXMOOEQIEMB-DZGCQCFKSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  22
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.37
• 拓扑面积：
  30.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (1S)-N-[[(7S)-2,5-dimethoxy-7-bicyclo[4.2.0]octa-1,3,5-trienyl]methyl]-1-phenylethanamine 在 palladium dihydroxide 水 、 氢气 作用下， 以 甲醇 为溶剂， 20.0 ℃ 、275.79 kPa 条件下， 反应 6.0h， 以92%的产率得到[(7S)-2,5-dimethoxy-7-bicyclo[4.2.0]octa-1,3,5-trienyl]methanamine
  参考文献：
  名称：

  1-Aminomethylbenzocycloalkanes:  Conformationally Restricted Hallucinogenic Phenethylamine Analogues as Functionally Selective 5-HT_2A Receptor Agonists

  摘要：

  A series of conformationally restricted analogues of the hallucinogenic phenethylamine 1 (2,5-dimethoxy4-bromophenethylamine, 2C-B) was synthesized to test several hypotheses concerning the bioactive conformation of phenethylamine ligands upon binding to the 5-HT2A receptor. These benzocycloalkane analogues were assayed for their receptor binding affinity and ability to activate downstream signaling pathways, and one exceptional compound was selected for testing in an in vivo drug discrimination model of hallucinogenesis. All compounds were examined in silico by virtual docking into a homology model of the 5-HT2A receptor. On the basis of these docking experiments, it was predicted that the R enantiomer of benzocyclobutene analogue 2 would be the most potent. Subsequent chemical resolution and X-ray crystallography confirmed this prediction, as (R)-2 proved to be equipotent to LSD in rats trained to discriminate LSD from saline. Thus, we propose that the conformation of 2 mimics the active binding conformation of the more flexible phenethylamine type hallucinogens. In addition, (R)-2 is one of the most potent and selective compounds yet discovered in the in vivo drug discrimination assay. Further, 2 was found to be a functionally selective agonist at the 5-HT2A receptor, having 65-fold greater potency in stimulating phosphoinositide turnover than in producing arachidonic acid release. If hallucinogenic effects are correlated with arachidonic acid production, such functionally selective 5-HT2A receptor agonists may lack the intoxicating properties of hallucinogens such as LSD.

  DOI：

  10.1021/jm060656o
• 作为产物：
  描述：

  在 硼烷 作用下， 以 四氢呋喃 为溶剂， 反应 1.0h， 生成 (1S)-N-[[(7R)-2,5-dimethoxy-7-bicyclo[4.2.0]octa-1,3,5-trienyl]methyl]-1-phenylethanamine 、 (1S)-N-[[(7S)-2,5-dimethoxy-7-bicyclo[4.2.0]octa-1,3,5-trienyl]methyl]-1-phenylethanamine
  参考文献：
  名称：

  1-Aminomethylbenzocycloalkanes:  Conformationally Restricted Hallucinogenic Phenethylamine Analogues as Functionally Selective 5-HT_2A Receptor Agonists

  摘要：

  A series of conformationally restricted analogues of the hallucinogenic phenethylamine 1 (2,5-dimethoxy4-bromophenethylamine, 2C-B) was synthesized to test several hypotheses concerning the bioactive conformation of phenethylamine ligands upon binding to the 5-HT2A receptor. These benzocycloalkane analogues were assayed for their receptor binding affinity and ability to activate downstream signaling pathways, and one exceptional compound was selected for testing in an in vivo drug discrimination model of hallucinogenesis. All compounds were examined in silico by virtual docking into a homology model of the 5-HT2A receptor. On the basis of these docking experiments, it was predicted that the R enantiomer of benzocyclobutene analogue 2 would be the most potent. Subsequent chemical resolution and X-ray crystallography confirmed this prediction, as (R)-2 proved to be equipotent to LSD in rats trained to discriminate LSD from saline. Thus, we propose that the conformation of 2 mimics the active binding conformation of the more flexible phenethylamine type hallucinogens. In addition, (R)-2 is one of the most potent and selective compounds yet discovered in the in vivo drug discrimination assay. Further, 2 was found to be a functionally selective agonist at the 5-HT2A receptor, having 65-fold greater potency in stimulating phosphoinositide turnover than in producing arachidonic acid release. If hallucinogenic effects are correlated with arachidonic acid production, such functionally selective 5-HT2A receptor agonists may lack the intoxicating properties of hallucinogens such as LSD.

  DOI：

  10.1021/jm060656o